Thromboembolism and bleeding in newly diagnosed multiple myeloma: rates, risk profile, and patterns of thromboprophylaxis

Background: Guidelines suggest pharmacological thromboprophylaxis for patients with multiple myeloma (MM) treated with immunomodulatory drugs due to a high risk of venous thromboembolisms (VTE). Objectives: To analyze rates of VTE and bleeding, risk profiles, and patterns of thromboprophylaxis in MM...

Description complète

Détails bibliographiques

Auteurs principaux:	Lea Vospernik, Hermine Agis, Cihan Ay, Lina Rüsing, Heinz Gisslinger, Christina Brunbauer, Clara Sophie Michel, Ingrid Simonitsch-Klupp, Alexandra Kaider, Maria-Theresa Krauth, Julia Riedl
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2025-08-01
Collection:	Research and Practice in Thrombosis and Haemostasis
Sujets:	Anticoagulants clinical decision rules hemorrhage multiple myeloma venous thromboembolism
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2475037925004868
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!